Loading
KL
Khiron Life Sciences Corp. Stock: price and insider trades · Canada
Khiron Life Sciences Corp.: what insiders have been doing
Khiron Life Sciences Corp. is a listed company. Its directors and officers file their transactions with SEDI. Khiron Life Sciences Corp. has had no insider filing for more than a year; the last one goes back to 30 April 2024.
Our records for Khiron Life Sciences Corp. go back to 2018, with 27 purchases and 6 sales on the open market in total.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
86
Thresholds
n/a
Buy Volume
€309,681
27 ops. · all time
Sell Volume
€272,050
6 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 30 April 2024
Declarations86 total
12,000 shares@ CA$0.105.3% of flowCommon SharesTSXSEDI:4305563
Canonical exit: 29 May 2023 (T+90)
238,000 shares@ CA$0.091294.7% of flowCommon SharesTSXSEDI:4305564
Canonical exit: 6 Jun 2023 (T+90)
100,000 shares@ CA$0.1512.9% of flowCommon SharesTSXSEDI:3961314
400,000 shares@ CA$0.15100.0% of flowCommon SharesTSXSEDI:3961320
Common SharesTSXSEDI:3961319
1,000,000 shares@ CA$0.1510.9% of flowCommon SharesTSXSEDI:3961323
400,000 shares@ CA$0.1512.2% of flowCommon SharesTSXSEDI:3961310
Common SharesTSXSEDI:3961103
Common SharesTSXSEDI:3961097
135,000 shares@ CA$0.15100.0% of flowCommon SharesTSXSEDI:3961098
150,000 shares@ CA$0.21577.9% of flowCommon SharesTSXSEDI:3855463
Canonical exit: 23 Mar 2022 (T+90)
240,000 shares@ CA$0.20517.2% of flowCommon SharesTSXSEDI:3854551
Canonical exit: 22 Mar 2022 (T+90)
50,000 shares@ CA$0.2984.4% of flowCommon SharesTSXSEDI:3802948
Canonical exit: 12 Dec 2021 (T+90)
15,000 shares@ CA$0.4658.9% of flowCommon SharesTSXSEDI:3757167
153,000 shares@ CA$0.464891.1% of flowCommon SharesTSXSEDI:3757168
500,000 sharesCommon SharesTSXSEDI:3756401
25,000 shares@ CA$0.39Common SharesTSXSEDI:3640864
Canonical exit: 9 Mar 2021 (T+90)
20,000 shares@ CA$0.387Common SharesTSXSEDI:3640858
Canonical exit: 11 Mar 2021 (T+90)
25,000 shares@ CA$0.391Common SharesTSXSEDI:3640866
Canonical exit: 10 Mar 2021 (T+90)
Common SharesTSXSEDI:3638473
20,000 shares@ CA$0.40Common SharesTSXSEDI:3638482
Canonical exit: 4 Mar 2021 (T+90)
Common SharesTSXSEDI:3603811
Common SharesTSXSEDI:3603467
10,000 shares@ CA$0.52Common SharesTSXSEDI:3598409
Canonical exit: 3 Dec 2020 (T+90)
75,000 shares@ CA$0.53Common SharesTSXSEDI:3598417
Canonical exit: 3 Dec 2020 (T+90)
25 of 86 declarations
About Khiron Life Sciences Corp.
Khiron Life Sciences Corp. is a Canadian company focused on the development and commercialization of cannabis-based products in the life sciences sector. It primarily operates on the TSX market.
